Denali Therapeutics is a biotechnology company specializing in the research and development of treatments for individuals suffering from neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, ALS, and others. Founded by scientists, industry experts, and investors who are dedicated to leveraging recent scientific breakthroughs in understanding the genetic causes and biological mechanisms of neurodegenerative diseases, Denali is committed to advancing innovative therapies to improve patient outcomes.^[0]

Among the notable investors in Denali is GV.